ACB

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ NASDAQ |  TSX: ACB EDMONTON, AB, Sept. 28, 2023 - Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has entered into an agreement pursuant to which Canaccord Genuity ha... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, Sept. 8, 2023 - Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $12.3 million (US$9.0 million) principal amount of its convertible senior notes ("Notes") in multiple transactio... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, Aug. 14, 2023 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held today, Monday, August 14, 2023 by virtual webcast. The... Read More...

NASDAQ | TSX: ACB Sourdough Shortcuts are now infused with live resin THCA diamonds, adding a super high potency offering to Aurora's portfolio of medical productsEDMONTON, AB, Aug. 1, 2023 -  Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, has launched its first high-potency infused pre-roll ... Read More...

"We continue to evolve our portfolio with the consumer and patient top-of-mind, developing products that deliver on both current and future wants and needs," says Lana Culley, Vice President of Product Development at Aurora Cannabis. "With the introduction of innovations like our snackable, low dose Lil' Bits and our XL premium resin vape... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, April 28, 2023 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today announced the expansion of its portfolio in Germany with the launch of... Read More...

Through Aurora's best-in-class genetics breeding program, backed by extensive consumer research and development, Aurora continues to focus on expanding its portfolio of product offerings, while developing unique cultivars and formats that appeal to a wide variety of patients and consumers. New products launching this April include:San Raf... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, April 24, 2023 - Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $22.3 million (US$16.6 million) principal amount of its convertible senior notes ("Notes") in multiple transact... Read More...

Available through MedReleaf's Concession Scheme, doctors and patients will have more freedom in choosing their cannabis medicationEDMONTON, AB, April 12, 2023 - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of IndiMed Tempo 26, a range ... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, March 30, 2023 - Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $46.6 million (US$34.3 million) principal amount of its convertible senior notes ("Notes") at a total cost, inc... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, March 24, 2023 - Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced receipt of a notification letter (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated March 24, 2023, advising that the Company was not in c... Read More...

NASDAQ | TSX: ACBCanada's leading medical cannabis provider and Australia's preeminent medical cannabis supplier to bring three new premium strains to Australian patientsEDMONTON, AB, Feb. 22, 2023 - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced t... Read More...

NASDAQ | TSX: ACB EDMONTON, AB, Jan. 4, 2023 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that the Company has closed the sale of its Aurora Polaris facility for gross proceeds of approximately $15 million, previously announ... Read More...

"We're proud to be recognized by some of the most important and influential members of the cannabis industry - retailers and budtenders," says Geoff Hoover, Senior Vice President of Consumer at Aurora Cannabis. "This award is a testament to our continued commitment to quality and our team's unwavering focus and passion for delivering only... Read More...

NASDAQ | TSX: ACB Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction EDMONTON, AB, Oct. 7, 2022 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of... Read More...

Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction EDMONTON, AB, June 3, 2022 - Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $25.3 million (US$20 million) principal amo... Read More...

State-of-the-art facility readying first delivery of medical grade cannabis for German patients EDMONTON, AB, May 18, 2022 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the company has received EU-GMP certification for its st... Read More...

Founded in 2018, Thrive is a licensed producer of super-premium cannabis concentrates and craft dried flower, and leverages innovative cultivation and extraction techniques with a singular focus on achieving the highest quality standards. Thrive is most widely known for its award-winning flagship recreational brand, Greybeard Cannabis Co.... Read More...

"We're excited to introduce KG7 to the Reliva family of leading CBD products," says Miguel Martin, Chief Executive Officer of Aurora Cannabis. "As part of Reliva's portfolio expansion strategy, KG7 extends our brand into additional CBD market segments. With this product line, we expect to solidify Reliva's position as the #1 CBD brand in ... Read More...

Newly created directorship to be filled by Chitwant Kohli, Senior Financial ExecutiveNASDAQ | TSX: ACB  Continue Reading Chitwant Kohli joins the Board of Directors for Aurora Cannabis (CNW Group/Aurora Cannabis Inc.) EDMONTON, AB, Jan. 4, 2022 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: AC... Read More...

NASDAQ | TSX: ACB  EDMONTON, AB, Dec. 13, 2021 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to acknowledge the Company's increased ranking in The Globe and Mail's 2021 annual Report on Business review of Corporate Boards, known a... Read More...

New Seasonal Offerings Slated for November Release  EDMONTON, AB, Oct. 28, 2021 - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing agreement with The Valens Company Inc. ("The Valens Company" or "Valens") a leading... Read More...